SEARCH

SEARCH BY CITATION

References

  • 1
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Goa F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556562.MEDLINE
  • 2
    Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:4152.MEDLINE
  • 3
    Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001; 33:321327.MEDLINE
  • 4
    Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, et al. The natural history of hepatitis C virus infection: host viral, and environmental factors. JAMA 2000; 284:450456.MEDLINE
  • 5
    Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol 1999; 31:1724.MEDLINE
  • 6
    Viladomiu L, Genesca J, Esteban JI, Allende H, Gonzalez A, Lopez-Talavera JC, Estaban R, et al. Interferon alpha in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology 1992; 15:767769.MEDLINE
  • 7
    Lampertico P, Rumi M, Romeo R, Craxì A, Soffredini R, Biassoni D, Columbo M. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994; 19:199202.
  • 8
    Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ. A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 1994; 21:831836.MEDLINE
  • 9
    Li XW, Zhu ZY, Dao WP, Liu FH, Die GS. A report on therapy of interferon alfa 2b in patients with acute hepatitis C. Chung Hua Nei Ko Tsa Chih 1993; 32:409411.MEDLINE
  • 10
    Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Tada M. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991; 338:914915.MEDLINE
  • 11
    Calleri G, Colombatto P, Gozzelino M, Chieppa F, Romano P, Delmastro B, Macor A, et al. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial. Ital J Gastroenterol Hepatol 1998; 30:181184.MEDLINE
  • 12
    Takano S, Satomura Y, Omata M. Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group. Gastroenterology 1994; 107:805811.MEDLINE
  • 13
    Fabris P, Tositti G, Giordani MT, Infantolino D, De Lalla F. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C. Am J Gastroenterol 2002; 97:492493.MEDLINE
  • 14
    Alberti A, Chemello L, Belussi F, Pontisso P, Tisminetsky S, Gerotto M, Baralle F, et al. Outcome of acute hepatitis C and role of alpha interferon therapy. In: NishiokaKSH, OdaT, eds. Viral Hepatitis and Liver Disease. Tokyo, Japan: Springer-Verlag, 1994; 604606.
  • 15
    Ohnishi K, Nomura F, Nakano M. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 1991; 86:10411049.MEDLINE
  • 16
    Palmovic D, Kurelac I, Crnjakovic-Palmovic J. The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha. Infection 1994; 22:222223.MEDLINE
  • 17
    Tassopoulos NC, Koutelou MG, Papatheodoridis G, Polychronaki H, Delladetsima I, Giannikakis T, Todoulos A, et al. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 1993; 34(Suppl 2):S130S132.MEDLINE
  • 18
    Gursoy M, Gur G, Arslan H, Ozdemir N, Boyacioglu S. Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment. J Viral Hepat 2001; 8:7077.MEDLINE
  • 19
    Vogel W, Graziadei I, Umlauft F, Datz C, Hackl F, Alliger S, Grunewald K, et al. High dose interferon alpha 2b treatment prevents chronicity in acute hepatitis C. A pilot study. Dig Dis Sci 1996; 41(Suppl 12):81S85S.MEDLINE
  • 20
    Pimstone NR, Powell JS, Kotfila R, Pimstone DJ, Davidson L. High dose (780 MIU/52 weeks) interferon monotherapy is highly effective treatment for acute hepatitis C [Abstract]. Gastroenterology 2000; 118:960A.
  • 21
    Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, et al. Treatment of acute hepatitis C with interferon alpha-2b. N Engl J Med 2001; 345:14521457.MEDLINE
  • 22
    Gerlach TJ, Zachoval R, Gruener N, Jung M-C, Ulsenheimer A, Schraut W, Schirren A, et al. Acute hepatitis C: natural course and response to antiviral treatment [Abstract]. Hepatology 2001; 34:341A.
  • 23
    Poynard T, Regime C, Myers RP, Thevenot T, Leroy V, Mathurin P, Opolon P, et al. Interferon for acute hepatitis C (Cochrane Review). In: The Cochrane Library, Issue 1, Oxford, UK, 2002.
  • 24
    Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Antoni AM, Pizzocolo G, et al. Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 1994; 1004:666671.
  • 25
    Kenny-Walsh E for the Irish Hepatology Research Group. Clinical outcomes after hepatitis infection from contaminated anti-globulin. N Engl J Med 1999; 340:12281233.MEDLINE
  • 26
    Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29:908914.MEDLINE
  • 27
    Cammà C, Craxì A. Interferon treatment for acute hepatitis C: a metaanalysis [Abstract]. Hepatology 2002 (in press).
  • 28
    Alberti A. Interferon therapy of acute hepatitis C. Viral Hepatitis Reviews 1995; 1:3745.
  • 29
    Hoofnagle JH. Therapy for acute hepatitis C. N Engl J Med 2001; 345:14951497.MEDLINE